# A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia

> **NCT00459745** · PHASE3 · COMPLETED · sponsor: **Shionogi** · enrollment: 481 (actual)

## Conditions studied

- Combined Hyperlipidemia

## Interventions

- **DRUG:** Pravafen
- **DRUG:** Pravastatin
- **DRUG:** Fenofibrate

## Key facts

- **NCT ID:** NCT00459745
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-04
- **Final completion:** 2009-07
- **Target enrollment:** 481 (ACTUAL)
- **Last updated:** 2018-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00459745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00459745, "A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00459745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*